Wolfe Research on Exact Sciences (EXAS): 'Cologuard Plus CLFS Rate Set At $592; Potential for ~$50MM Upside To '25 Revenue'
Tweet Send to a Friend
Wolfe Research analyst Doug Schenkel reiterated an Outperform rating and $70.00 price target on Exact Sciences (NASDAQ: EXAS)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
